Karuna Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Karuna Therapeutics

03/08/2023 14:35

* Karuna Therapeutics Inc  KRTX.OQ  reported a quarterly
adjusted
loss of $2.75​​ per share for the quarter ended in June. The
mean expectation of seventeen analysts for the quarter was for a
loss of $2.78 per share.
    * Reported revenue was zero​; analysts expected $365.00
thousand. 
    * Karuna Therapeutics Inc's reported EPS for the quarter was
a
loss of $2.75​.
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Karuna Therapeutics Inc shares had fallen by 8.8% this
quarter and gained 0.6% so far this year.
    * The company reported a quarterly loss of $103.16 million.
    * Wall Street's median 12-month price target for Karuna
Therapeutics Inc is $280.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 01:34 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -2.78          -2.75          Beat
 Mar. 31 2023      -2.76          -2.80          Missed
 Dec. 31 2022      -2.25          -2.22          Beat
 Sep. 30 2022      -2.13          -2.38          Missed